1956
DOI: 10.1172/jci103380
|View full text |Cite
|
Sign up to set email alerts
|

Studies of the Anemia and Iron Metabolism in Cancer 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
15
0
1

Year Published

1957
1957
1974
1974

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(18 citation statements)
references
References 26 publications
2
15
0
1
Order By: Relevance
“…The spleens of these animals synthesize both hemoglobin and ferritin at an increased rate. These results could explain the increased uptake of 59Fe by the spleen of tumorbearing mice, reported by Hevesy and Lockner (21), and may be applicable to the observations made in human malignancies of an anemia not associated with blood loss (22) and to the reports of an increased quantity of total iron in their spleens (23). The origin of spleen erythropoietic stimulation in animals bearing the tumor may be ascribed to hypoxia resulting from loss of bone marrow erythropoietic activity, or to a shortened life span of the circulating erythrocytes (21).…”
Section: Resultssupporting
confidence: 72%
“…The spleens of these animals synthesize both hemoglobin and ferritin at an increased rate. These results could explain the increased uptake of 59Fe by the spleen of tumorbearing mice, reported by Hevesy and Lockner (21), and may be applicable to the observations made in human malignancies of an anemia not associated with blood loss (22) and to the reports of an increased quantity of total iron in their spleens (23). The origin of spleen erythropoietic stimulation in animals bearing the tumor may be ascribed to hypoxia resulting from loss of bone marrow erythropoietic activity, or to a shortened life span of the circulating erythrocytes (21).…”
Section: Resultssupporting
confidence: 72%
“…Failure of iron utilization has been described in these disorders (2,3), and studiesof mobilizable iron support this finding (4). A detailed understanding of the pathogenesis of the marrow failure is limited by incomplete knowledge about the normal development and function of the erythroid series and modification of these processes by disease.…”
Section: Introductionmentioning
confidence: 97%
“…Anemia commonly occurs in chronic infection, inflammation, and malignancy (1)(2)(3)(4). This anemia is characReceived for publication 14 June 1973 and in revised form 10 December 1973. terized by: (a) decreased plasma iron and iron-binding capacity; (b) impaired release of reticuloendothelial iron into the plasma; (c) modest decrease of red cell survival; and (d) relative failure of bone marrow to increase red cell production (1)(2)(3)(4)(5)(6)(7).…”
Section: Introductionmentioning
confidence: 99%
“…This anemia is characReceived for publication 14 June 1973 and in revised form 10 December 1973. terized by: (a) decreased plasma iron and iron-binding capacity; (b) impaired release of reticuloendothelial iron into the plasma; (c) modest decrease of red cell survival; and (d) relative failure of bone marrow to increase red cell production (1)(2)(3)(4)(5)(6)(7). These clinical similarities have resulted in the classification of these anemias in a single category, the anemia of chronic disorders (ACD)1 (8).…”
Section: Introductionmentioning
confidence: 99%